CV Sciences (CVSI) Capital Expenditures Growth (5y) (2018 - 2026)
CV Sciences (CVSI) Capital Expenditures Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | CV Sciences | 3.90 Mn | 3.63 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.82% |
| Dec 31, 2025 | -59.42% |
| Sep 30, 2025 | 15.34% |
| Jun 30, 2025 | -35.23% |
| Mar 31, 2025 | -12.05% |
| Dec 31, 2024 | -56.27% |
| Dec 31, 2020 | 103.32% |
| Sep 30, 2020 | -1,117.03% |
| Jun 30, 2020 | 94.91% |
| Mar 31, 2020 | 0.35% |
| Dec 31, 2019 | 61.83% |
| Sep 30, 2019 | -17.26% |
| Jun 30, 2019 | -24.56% |
| Dec 31, 2018 | 103.81% |
| Jun 30, 2018 | -58.82% |